193 related articles for article (PubMed ID: 34876325)
21. TSC2/PKD1 contiguous gene syndrome: a report of 2 cases with emphasis on dermatopathologic findings.
Kacerovska D; Vrtel R; Michal M; Vanecek T; Vodicka R; Kreuzberg B; Ricarova R; Pizinger K; Danis D; Reischig T; Kazakov DV
Am J Dermatopathol; 2009 Aug; 31(6):532-41. PubMed ID: 19590422
[TBL] [Abstract][Full Text] [Related]
22. [TSC2/PKD1 contiguous gene deletion syndrome].
Llamas Velasco S; Camacho Salas A; Vidales Moreno C; Ceballos Rodríguez RM; Murcia García FJ; Simón de la Heras R
An Pediatr (Barc); 2013 Jul; 79(1):42-5. PubMed ID: 23402778
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis and genotype-phenotype correlation in patients with PKD1/TSC2 contiguous gene deletion syndrome.
Shang S; Mei Y; Wang T; Zheng X; Chen K; Xiong S; Dong Y; Chang Y; Wu X; Kong X; Tan M; Wu L; Zhang Y; Xiao Y; Xie Y; Cai G; Chen X; Li Q
Clin Nephrol; 2022 Jun; 97(6):328-338. PubMed ID: 35142283
[TBL] [Abstract][Full Text] [Related]
24. A Case Report of Tuberous Sclerosis and Autosomal Dominant Polycystic Kidney Disease in the Era of Tolvaptan.
Guerra-Torres XE
Curr Rev Clin Exp Pharmacol; 2023; 18(3):284-290. PubMed ID: 35585803
[TBL] [Abstract][Full Text] [Related]
25. Facilitated diagnosis of the contiguous gene syndrome: tuberous sclerosis and polycystic kidneys by means of haplotype studies.
Torra R; Badenas C; Darnell A; Camacho JA; Aspinwall R; Harris PC; Estivill X
Am J Kidney Dis; 1998 Jun; 31(6):1038-43. PubMed ID: 9631851
[TBL] [Abstract][Full Text] [Related]
26. Molecular analysis of TSC2/PKD1 contiguous gene deletion syndrome.
Oyazato Y; Iijima K; Emi M; Sekine T; Kamei K; Takanashi J; Nakao H; Namai Y; Nozu K; Matsuo M
Kobe J Med Sci; 2011 Jun; 57(1):E1-10. PubMed ID: 22169896
[TBL] [Abstract][Full Text] [Related]
27. Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas.
Henske EP; Neumann HP; Scheithauer BW; Herbst EW; Short MP; Kwiatkowski DJ
Genes Chromosomes Cancer; 1995 Aug; 13(4):295-8. PubMed ID: 7547639
[TBL] [Abstract][Full Text] [Related]
28. Generation of iPSC from peripheral blood mononuclear cells obtained from a patient with TSC2-PKD1 contiguous gene deletion syndrome.
Li J; Shang S; Wang T; Fu B; Wang P; Cai G; Chen X; Li Q
Stem Cell Res; 2021 Mar; 51():102181. PubMed ID: 33485185
[TBL] [Abstract][Full Text] [Related]
29. Malignant tumors in tuberous sclerosis complex: a case report and review of the literature.
Liu C; Lele SM; Goodenberger MH; Reiser GM; Christiansen AJ; Padussis JC
BMC Med Genomics; 2024 May; 17(1):144. PubMed ID: 38802873
[TBL] [Abstract][Full Text] [Related]
30. The Importance of Genetic Testing in the Differential Diagnosis of Atypical TSC2-PKD1 Contiguous Gene Syndrome-Case Series.
Orosz P; Kollák Z; Pethő Á; Fogarasi A; Reusz G; Hadzsiev K; Szabó T
Children (Basel); 2023 Feb; 10(3):. PubMed ID: 36979978
[TBL] [Abstract][Full Text] [Related]
31. TSC2/PKD1 contiguous deletion syndrome in a pregnant woman: A case report.
Huang S; Xu K; Xu Y; Zhao L; He X
Front Med (Lausanne); 2023; 10():1101079. PubMed ID: 36895714
[TBL] [Abstract][Full Text] [Related]
32. Atypical tuberous sclerosis complex presenting as familial renal cell carcinoma with leiomyomatous stroma.
Bah I; Fahiminiya S; Bégin LR; Hamel N; D'Agostino MD; Tanguay S; Foulkes WD
J Pathol Clin Res; 2018 Jul; 4(3):167-174. PubMed ID: 29659200
[TBL] [Abstract][Full Text] [Related]
33. A tuberous sclerosis patient with a large TSC2 and PKD1 gene deletion shows extrarenal signs of autosomal dominant polycystic kidney disease.
Longa L; Brusco A; Carbonara C; Polidoro S; Scolari F; Valzorio B; Riegler P; Tardanico R; Migone N
Contrib Nephrol; 1997; 122():91-5. PubMed ID: 9399046
[No Abstract] [Full Text] [Related]
34. Renal phenotypes correlate with genotypes in unrelated individuals with tuberous sclerosis complex in China.
Luo C; Zhang Y; Zhang YS; Zhang MX; Ning J; Chen MF; Li Y; Qi L; Zu XB; Li YL; Cai Y
Orphanet J Rare Dis; 2022 Jul; 17(1):288. PubMed ID: 35870981
[TBL] [Abstract][Full Text] [Related]
35. Tuberous sclerosis complex with autosomal dominant polycystic kidney disease: a rare duo.
Rijal JP; Dhakal P; Giri S; Dahal KV
BMJ Case Rep; 2014 Dec; 2014():. PubMed ID: 25519866
[TBL] [Abstract][Full Text] [Related]
36. Renal Cell Carcinoma in Tuberous Sclerosis Complex.
Henske EP; Cornejo KM; Wu CL
Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34680979
[TBL] [Abstract][Full Text] [Related]
37. Cluster of differentiation 8 and programmed cell death ligand 1 expression in triple-negative breast cancer combined with autosomal dominant polycystic kidney disease and tuberous sclerosis complex: a case report.
Gonda K; Akama T; Nakamura T; Hashimoto E; Kyoya N; Rokkaku Y; Maejima Y; Horita S; Tachibana K; Abe N; Ohtake T; Shimomura K; Kono K; Saji S; Takenoshita S; Higashihara E
J Med Case Rep; 2019 Dec; 13(1):381. PubMed ID: 31870441
[TBL] [Abstract][Full Text] [Related]
38. Endovascular treatment of intrarenal aneurysms bleeding and angiomyolipomas in a patient with tuberous sclerosis and polycystic kidney disease.
Leite T; Pazinato LV; Vidal MJA; Freitas D; Leal Filho JMM
J Bras Nefrol; 2023; 45(1):111-115. PubMed ID: 34328493
[TBL] [Abstract][Full Text] [Related]
39. Pediatric Renal Angiomyolipomas in Tuberous Sclerosis Complex.
Warncke JC; Brodie KE; Grantham EC; Catarinicchia SP; Tong S; Kondo KL; Cost NG
J Urol; 2017 Feb; 197(2):500-506. PubMed ID: 27678300
[TBL] [Abstract][Full Text] [Related]
40. Tuberous sclerosis complex with polycystic kidney disease of the adult type: the TSC2/ADPKD1 contiguous gene syndrome.
Bisceglia M; Galliani C; Carosi I; Simeone A; Ben-Dor D
Int J Surg Pathol; 2008 Oct; 16(4):375-85. PubMed ID: 18611938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]